Trial Profile
A Retrospective Cohort Study Describing The Characteristics, Treatment Utilization and Short Term Outcomes of Type 2 Diabetes Mellitus Patients Treated With Canagliflozin In The Real World Using A Large US Health Plan Database (Optum Research Database: 3 Month Follow Up Study).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2016
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Oct 2016 New trial record